Psychiatry Research: Neuroimaging
Volume 171, Issue 3 , Pages 221-231 , 31 March 2009

Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment

  • Pei-Ning Wang

      Affiliations

    • Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. The Neurological Institute, Taipei Veterans General Hospital, Taipei, 112, Taiwan. Tel.: +886 2 2875 7578; fax: +886 2 2873 8696.
    • ,
  • Hsiu-Chih Liu

      Affiliations

    • Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan
    • ,
  • Jiing-Feng Lirng

      Affiliations

    • Department of Radiology, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan
    • ,
  • Ker-Neng Lin

      Affiliations

    • Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Department of Psychology, Fu Jen Catholic University, Taipei County, Taiwan
    • ,
  • Zin-An Wu

      Affiliations

    • Department of Neurology, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Department of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan

Received 10 October 2007 ,Revised 17 March 2008 ,Accepted 7 May 2008.

References 

  1. Aartsen MJ, Martin M, Zimprich D. Gender differences in level and change in cognitive functioning. Results from the Longitudinal Aging Study Amsterdam. Gerontology. 2004;50:35–38
  2. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198–205
  3. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Archives of General Psychiatry. 2001;58:853–858
  4. Coffey CE, Wilkinson WE, Parashos LA, Soady SAR, Sullivan RJ, Patterson LJ, et al. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology. 1992;42:527–536
  5. Cohen RM, Small C, Lalonde F, Friz J, Sunderland T. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology. 2001;57:2223–2228
  6. Corder E, Basun H, Lannfelt L, Viitanen M, Winblad B. Apolipoprotein E-epsilon 4 gene dose. Lancet. 1995;346:967–968
  7. de Leon MJ, Convit A, George AE, Golomb J, de Santi S, Tarshish C, et al. In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease. Annals of the New York Academy of Sciences. 1996;777:1–13
  8. de Toledo-Morrell L, Dickerson B, Sullivan MP, Spanovic C, Wilson R, Bennett DA. Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus. 2000;10:136–142
  9. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MMB. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology. 2002;59:746–748
  10. Du AT, Schuff N, Kramer JH, Ganzer S, Zhu XP, Jagust WJ, et al. Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology. 2004;62:422–427
  11. Du AT, Schuff N, Chao LL, Kornak J, Jagust WJ, Kramer JH, et al. Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiology of Aging. 2006;27:733–740
  12. Farlow MR, He Y, Tekin S, Xu J, Lane R, Charles HC. Impact of APOE in mild cognitive impairment. Neurology. 2004;63:1898–1901
  13. Geroldi C, Pihlajamaki M, Laakso MP, DeCarli C, Beltramello A, Bianchetti A, et al. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology. 1999;53:1825–1832
  14. Hamalainen A, Tervo S, Grau-Olivares M, Niskanen E, Pennanen C, Huuskonen J, et al. Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. NeuroImage. 2007;37:1122–1131
  15. Hong CJ, Liu TY, Liu HC, Wang SJ, Fuh JL, Chi CW, et al. Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population. Neurology. 1996;46:1749–1751
  16. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Britsh Journal of Psychiatry. 1982;140:566–572
  17. Jack CR, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 1998;51:993–999
  18. Jack CR, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52:1397–1403
  19. Jack CR, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology. 2000;55:484–489
  20. Jack CR, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology. 2004;62:591–600
  21. Jack CR, Petersen RC, Grundman M, Jin S, Gamst A, Ward , et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiology of Aging. 2008;29:1285–1295
  22. Laakso MP, Soininen H, Partanen K, Lehtovirta M, Hallikainen M, Hanninen T, et al. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiology of Aging. 1998;19:23–31
  23. Lahiri DK, Sambamurti K, Bennett DA. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiology of Aging. 2004;25:651–660
  24. Laursen P. The impact of aging on cognitive functions. An 11 year follow-up study of four age cohorts. Acta Neurologica Scandinavica Supplement. 1997;172:7–86
  25. Lehericy S, Baulac M, Chiras J, Pierot L, Martin N, Pillon B, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR American Journal of Neuroradiology. 1994;15:929–937
  26. Lin KN, Liu HC, Wang PN, Liao YC. Early detection of memory impairment: the use of the 12-item selective reminding test in Taiwan. In: Paper read at the 10th international conference on Alzheimer's disease and related disorders, July 18, at Madrid, Spain. 2006;
  27. Mayeux R, Small SA, Tang M, Tycko B, Stern Y. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E. Neurobiology of Aging. 2001;22:683–689
  28. Moffat SD, Szekely CA, Zonderman AB, Kabani NJ, Resnick SM. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology. 2000;55:134–136
  29. Mungas D, Harvey D, Reed BR, Jagust WJ, DeCarli C, Beckett L, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 2005;65:565–571
  30. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso MP, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging. 2004;25:303–310
  31. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology. 1999;56:303–308
  32. Rodrigue KM, Raz N. Shrinkage of the entorhinal cortex over five years predicts memory performance in healthy adults. Journal of Neuroscience. 2004;24:956–963
  33. Rusinek H, De Santi S, Frid D, Tsui WH, Tarshish CY, Convit A, et al. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology. 2003;229:691–696
  34. Shadlen MF, Larson EB, Gibbons LE, Rice MM, McCormick WC, Bowen J, et al. Ethnicity and cognitive performance among older African Americans, Japanese Americans, and Caucasians: the role of education. Journal of American Geriatric Society. 2001;49:1371–1378
  35. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Archives of Neurology. 2000;57:839–844
  36. Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Jicha GA, Cooper G, et al. Brain structural alterations before mild cognitive impairment. Neurology. 2007;68:1268–1273
  37. Stewart ST, Zelinski EM, Wallace RB. Age, medical conditions, and gender as interactive predictors of cognitive performance: the effects of selective survival. Journals of Gerontology Series B: Psychological Sciences and Social Sciences. 2000;55:P381–383
  38. Storandt M, Grant EA, Miller JP, Morris JC. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology. 2006;67:467–473
  39. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Archives of General Psychiatry. 2006;63:916–924
  40. Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, et al The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. International Psychogeriatrics. 1994;6:45–58discussion 62
  41. van de Pol LA, Hensel A, Barkhof F, Gertz HJ, Scheltens P, van der Flier WM. Hippocampal atrophy in Alzheimer disease: age matters. Neurology. 2006;66:236–238
  42. Van Hoesen GW, Hyman BT. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Progress in Brain Research. 1990;83:445–457
  43. Wang PN, Lirng JF, Lin KN, Chang FC, Liu HC. Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan. Neurobiology of Aging. 2006;27:1797–1806
  44. Whitwell, J.L., Shiung, M.M., Przybelski, S.A., Weigand, S.D., Knopman, D.S., Boeve, B.F., Petersen, R.C., Jack, C.R., Jr., 2008. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.
  45. Wolf H, Jelic V, Gertz HJ, Nordberg A, Julin P, Wahlund LO. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurologica Scandinavica Supplement. 2003;179:52–76
  46. Xu Y, Jack CR, O'Brien PC, Kokmen E, Smith GE, Ivnik RJ, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 2000;54:1760–1767

PII: S0925-4927(08)00071-1

doi: 10.1016/j.pscychresns.2008.05.002

Psychiatry Research: Neuroimaging
Volume 171, Issue 3 , Pages 221-231 , 31 March 2009

Article Tools

* Image Usage & Resolution